Dominic Ash

Characterising demographic contributions to observed population change in a declining migrant bird

I. R. Hartley, I. Henderson, J. Border, 2017 .

Functional and quality of life outcomes of localised prostate cancer treatments (Prostate Testing for Cancer and Treatment [ProtecT] study)

Catherine J. Grey, Susan N Moore, P. Fayers, 2022, Bju International.

Patient‐reported outcomes in the ProtecT randomized trial of clinically localized prostate cancer treatments: study design, and baseline urinary, bowel and sexual function and quality of life

Joyce E. Wilkinson, T. Peters, P. Fayers, 2016, BJU international.

Ten-year Mortality, Disease Progression, and Treatment-related Side Effects in Men with Localised Prostate Cancer from the ProtecT Randomised Controlled Trial According to Treatment Received.

T. Peters, P. Fayers, D. Aston, 2019, European urology.

Radiotherapy for Prostate Cancer: is it 'what you do' or 'the way that you do it'? A UK Perspective on Technique and Quality Assurance.

Susan N Moore, P. Fayers, D. Aston, 2016, Clinical oncology (Royal College of Radiologists (Great Britain)).

Functional and quality of life outcomes of localised prostate cancer treatments (Prostate Testing for Cancer and Treatment [ProtecT] study)

D. Aston, J. Oxley, F. Hamdy, 2022, BJU international.

Patient‐reported outcomes in the ProtecT randomized trial of clinically localized prostate cancer treatments: study design, and baseline urinary, bowel and sexual function and quality of life

Joyce E. Wilkinson, T. Peters, P. Fayers, 2016, BJU international.